Log in to save to my catalogue
Log in to save to my catalogue

Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic...

| Ask | Become a Library member

Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1702089910

Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia

About this item

Full title

Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia

Author / Creator

Lucijanic, Marko , Lasan-Trcic, Ruzica , Kusec, Rajko , Pejsa, Vlatko , Stoos-Veic, Tajana and Jaksic, Ozren

Journal title

Annals of hematology, 2015, Vol.94 (9), p.1617-1619

Language

English

Formats

Reports

More information

Alternative Titles

Full title

Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1702089910

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1702089910

Other Identifiers

E-ISSN

1432-0584

DOI

10.1007/s00277-015-2428-6

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections